Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer by enhancing TRIB1 and HDAC activity, as reported by et al. in Cell Death & Disease (2017).

Authors

• Person: Not available Organization: Nature
  Cellular rejuvenation: molecular mechanisms and potential ... - Nature

Sources

• Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com Nature via serper

Referenced by nodes (2)

• cisplatin concept
• non-small cell lung cancer concept